United-Guardian (NASDAQ:UG) Stock Breaks Above 200 Day Moving Average – What’s Next?

United-Guardian, Inc. (NASDAQ:UG) crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $6.95 and traded as high as $7.07. United-Guardian shares last traded at $7.07, with a volume of 15,715 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of United-Guardian in a report on Monday, October 19th. One investment analyst has rated the stock with a Hold rating. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

United-Guardian Stock Up 6.2%

The firm’s 50 day simple moving average is $7.05 and its 200 day simple moving average is $6.95. The company has a market cap of $32.45 million, a price-to-earnings ratio of 13.09 and a beta of 0.95.

United-Guardian (NASDAQ:UG) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.16 earnings per share (EPS) for the quarter. United-Guardian had a return on equity of 22.24% and a net margin of 22.01%. The business had revenue of $3.11 million during the quarter.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Gamco Investors INC. ET AL lifted its holdings in United-Guardian by 1.2% in the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock worth $1,101,000 after purchasing an additional 1,888 shares during the period. United Capital Financial Advisors LLC acquired a new position in United-Guardian during the 2nd quarter valued at about $143,000. Finally, BlackRock Inc. acquired a new position in United-Guardian during the 2nd quarter valued at about $105,000. 23.16% of the stock is owned by institutional investors and hedge funds.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.